Autopsy report · NCT02354911

Autologous Immunoregulatory Dendritic Cells for Type 1 Diabetes Therapy

“Funding for study not procured.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

DiaVacs, Inc.

Sponsor type

Industry

Conditions

Type 1 Diabetes

Interventions

Immunoregulatory Dendritic Cells; Placebo Comparator: Placebo Control

Participants

0

Trials that died the same way

• Advancing Adolescent Screening and Brief Intervention Protocols in Primary Care Settings
  “Study not funded.” (86% match in meaning)
• Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
  “No funding for the study” (82% match in meaning)
• Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography
  “Funding for the study could not be obtained.” (80% match in meaning)
• Vasomotor Symptoms and Cardiovascular Control
  “No funding obtained to conduct study” (79% match in meaning)
• Xanthine Oxidase Inhibition in Renal Transplant Recipients
  “Study was not funded” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.